Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500.
2015-2019 Germany Automated Microbiology Market is a new analysis of major business opportunities emerging in the German automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.
The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding German microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Market Segmentation Analysis
- Sales and market shares for major suppliers by individual test.
- Volume and sales forecasts for over 100 infectious disease
assays by individual test:
- Test volume estimates by method (molecular, serology/immunodiagnostics,
- Review of the market dynamics, trends, structure, size, growth
and major suppliers.
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Microbial Identification
- Antibiotic Susceptibility
- Urine Screening
- Blood Cultures
Review of Major Automated Systems
- Review of major automated molecular diagnostic, multipurpose, specialized,
microbial identification, antibiotic susceptibility, blood culture, urine screening,
and immunodiagnostic analyzers.
- The report profiles analyzers manufactured by Abbott, Alifax, Anagen,
BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad,
Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J,
Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens,
Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay,and other technologies and their potential
applications for the microbiology market.
- Global listings of companies developing or marketing microbiology
products by individual test.
- Strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative
arrangements and new products in R&D.
- The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies,
Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux,
Bio-Rad, Biotest, Cepheid, CellMark Forensics/LabCorp, Decode Genetics, Diadexus, Diamedix, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Exact Sciences, Fujirebio, Grifols, Hologic/Gen-Probe, Illumina, ID Biomedical/GSK, Kreatech/Leica, Li-Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics, Ortho-Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Siemens, Sierra Molecular, Shimadzu, Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.
Opportunities and Strategic Recommendations
- Emerging opportunities for new analyzers, reagents kits,
IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Contains 420 pages and 78 tables
SIMILAR MARKET STUDIES
This report provides an overview of the UK infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Table of ContentsBusiness EnvironmentMarket Structure Market Size, Growth, and Major Suppliers Market SharesList of Tables Test Volume Forecasts by Market ...
July 2015 | $0 | View Details >>
US Critical Care Diagnostics Market in Ancillary Hospital Locations ERs ORs ICUCCUs Test Volume and Sales Segment Forecasts Supplier Shares Competitive Strategies Innovative Technologies Instrumentation Review
This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.
July 2016 | $0 | View Details >>
2014 Analysis of the Beta-2 Microglobulin Testing Market: US, Europe France, Germany, Italy, Spain, UK, Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising ...
November 2013 | $2800 | View Details >>
2017 Argentina Hemostasis Diagnostics Market: Reagent, Analyzer and Volume Forecasts for 40 Assays, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers
Summary This comprehensive report from VPGMarketResearch.com contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years. The report explores market and technological trends; provides reagent, instrument and test volume for 40 coagulation procedures; compares features ...
January 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research